AKT1 and breast carcinoma: The same group reported that miR-204 reduced the expression and phosphorylation of 13 proteins involved in the PI3K/AKT, RAF1/MAPK, VEGF, and FAK/SRC signaling pathways in MDA-MB-231 breast cancer cell line.